NDC 0088-0576

Rifater

Rifampin, Isoniazid And Pyrazinamide

Rifater is a Oral Tablet, Sugar Coated in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin; Isoniazid; Pyrazinamide.

Product ID0088-0576_2209334f-337a-4dd3-82e4-64ffe1895ff3
NDC0088-0576
Product TypeHuman Prescription Drug
Proprietary NameRifater
Generic NameRifampin, Isoniazid And Pyrazinamide
Dosage FormTablet, Sugar Coated
Route of AdministrationORAL
Marketing Start Date1994-05-31
Marketing CategoryNDA / NDA
Application NumberNDA050705
Labeler Namesanofi-aventis U.S. LLC
Substance NameRIFAMPIN; ISONIAZID; PYRAZINAMIDE
Active Ingredient Strength120 mg/1; mg/1; mg/1
Pharm ClassesRifamycin Antibacterial [EPC],Rifamycins [CS],Antimycobacterial [EPC],Antimycobacterial [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0088-0576-41

60 TABLET, SUGAR COATED in 1 BOTTLE (0088-0576-41)
Marketing Start Date1994-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0088-0576-41 [00088057641]

Rifater TABLET, SUGAR COATED
Marketing CategoryNDA
Application NumberNDA050705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1994-05-31

Drug Details

Active Ingredients

IngredientStrength
RIFAMPIN120 mg/1

OpenFDA Data

SPL SET ID:429a2f62-9fe6-4299-b314-92a9d22b1381
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198384
  • 206698
  • Pharmacological Class

    • Rifamycin Antibacterial [EPC]
    • Rifamycins [CS]
    • Antimycobacterial [EPC]
    • Antimycobacterial [EPC]

    Trademark Results [Rifater]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RIFATER
    RIFATER
    74146551 1866178 Live/Registered
    AVENTISUB LLC
    1991-03-11
    RIFATER
    RIFATER
    73482128 1321748 Dead/Cancelled
    Merrell Dow Pharmaceuticals Inc.
    1984-05-25

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.